scispace - formally typeset
D

Deanna Toema

Researcher at University of Maryland, Baltimore

Publications -  5
Citations -  651

Deanna Toema is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Salmonella & Population. The author has an hindex of 4, co-authored 5 publications receiving 497 citations.

Papers
More filters
Journal ArticleDOI

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study

TL;DR: A quantitative molecular diagnostic approach improved population-level and case-level characterisation of the causes of diarrhoea and indicated a high burden of disease associated with six pathogens, for which targeted treatment should be prioritised.
Journal ArticleDOI

Detection of Typhoidal and Paratyphoidal Salmonella in Blood by Real-time Polymerase Chain Reaction

TL;DR: It is recommended that future field trials of this clyA-based real-time polymerase chain reaction (qPCR) method and other novel diagnostics that detect typhoidal and nontyphoidal Salmonella employ multiple methodologies to define a "positive" sample.
Journal ArticleDOI

Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.

TL;DR: It is found that significant protection could be achieved with two COPS:FliC doses, despite elicitation of modest serum anti-COPS IgG antibody titers, which guide potential immunization strategies that may be translated to develop a human pediatric iNTS vaccine for sub-Saharan Africa.
Journal ArticleDOI

The Clinical Presentation of Culture-positive and Culture-negative, Quantitative Polymerase Chain Reaction (qPCR)-Attributable Shigellosis in the Global Enteric Multicenter Study and Derivation of a Shigella Severity Score: Implications for Pediatric Shigella Vaccine Trials.

TL;DR: A composite severity score consistent with severe disease or dysentery may be a pragmatic clinical endpoint for severe shigellosis in vaccine trials.